UMP (00722) Reports Annual Results with Shareholders' Profit of HK$31.44 Million, Down 22.6% Year-on-Year
Stock News
Sep 17
UMP (00722) announced its annual results for the year ended June 30, 2025, reporting revenue of HK$727 million, representing a 2.9% year-on-year decline. Profit attributable to owners reached HK$31.44 million, down 22.6% compared to the previous year. Basic earnings per share stood at 3.98 HK cents, with a proposed final dividend of 1.90 HK cents per share.
The year-on-year decrease in total revenue was primarily attributed to the offsetting effect of increased revenue from corporate healthcare solutions business against a significant decline in immigration medical examination volumes and reduced clinical medical services revenue.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.